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ORIGINAL ARTICLE 
Evaluation of the Roche Amplicor polymerase chain 
reaction assay for detection of enteroviruses in 
cerebrospinal fluid and its potential impact on patient 
management 
David W Robinson and Katherine R. Kociuba 
South Western Area Pathology Service, Department of Microbiology and Infectious Diseases, 
Liverpool, New South Wales, Australia 
Objective: To evaluate the Roche Amplicor polymerase chain reaction assay (APCR) by comparing the detection of 
enteroviruses from cerebrospinal fluid (CSF) by the Roche assay with detection by viral culture and to  determine whether 
routine use of enteroviral PCR will affect patient management. 
Methods: One hundred and sixty-three CSF specimens were tested by APCR and viral culture. Some of the discrepant 
specimens were resolved by retesting with an in-house PCR assay. Other discrepant results were resolved by testing 
the patients' serum by APCR or by viral culture of throat and stool specimens. 
Results: Thirty CSF specimens were positive by APCR, and 18 of these were positive by viral culture. There were no 
APCR-negative, viral-culture-positive CSF specimens. Six of the 12 discrepant specimens were resolved as true positives. 
Conclusions: The APCR assay was more rapid and sensitive than viral culture for detection of enteroviruses from CSF. 
Routine use of this assay has the potential t o  reduce the amount of antibiotics used and the number of patient days 
spent in hospital. 
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INTRODUCTION 
The decision as to whether a patient has viral or 
bacterial meningitis based upon presenting symptoms 
or preliminary pathology results is often difficult. Until 
recently, viral culture was the best method available for 
detection of enteroviral meningitis. However, isolation 
of enteroviruses fiom cerebrospinal fluid (CSF) is often 
slow, generally taking an average of 5 days before a viral 
cytopathic effect is observed. 
In the past few years, several in-house polymerase 
chain reaction (PCR) assays have been developed for 
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the detection of enteroviruses fiom various specimens, 
including CSF, serum, stool, throat swabs/washmgs, 
urine, vesicle fluid, whole blood, nasopharyngeal 
aspirates, pericardial effusion and mycocardial tissue 
[l-141. These assays are capable of detecting entero- 
viruses with a significantly higher degree of sensitivity 
and in a shorter time than viral culture. Roche seems 
to have addressed many of the shortcomings of in- 
house PCR with the development of the Amplicor 
enterovirus PCR assay (Roche Molecular Systems, 
Basle, Switzerland). The assay can be performed in 5 h 
and incorporates a single reverse transcription and 
amplification reaction by the use of the enzyme, rTth. 
Uracyl-N-glycosylase (UNG) is used to destroy any 
contaminating PCR product fiom previous reactions. 
The greatest advantage of the routine use of this assay 
is the incorporation of an enzyme immunoassay (E1A)- 
based, colorimetric detection system which is both 
rapid and easy to perform. We evaluated the Roche 
Amplicor enterovirus PCR assay for routine use in our 
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diagnostic laboratory. We established the potential for 
reduction in hospital costs by introduction of the 
routine use of the Roche PCR assay. 
MATERIALS AND METHODS 
Clinical specimens 
A retrospective study of 163 patients suspected ofhaving 
viral meningitis was conducted. Viral meningitis was 
suspected in these patients due to CSF pleocytosis 
without evidence of bacteria and because viral studies 
were requested by the clinician. A normal CSF white 
cell count (WCC) is interpreted in our laboratory as 
<5 cells/mm3 [lS]. One hundred and sixty-three CSF 
specimens were submitted to our diagnostic laboratory 
for viral culture between September 1994 and January 
1996. No bacteria were isolated from any of these CSF 
specimens. 
Viral culture 
After CSF specimens were processed for bacterial 
culture, 200-500 pL was inoculated per cell line into 
MRC-5 and cynomolgous monkey kidney cells 
(CMK). Specimens were processed either immediately 
upon arrival within the laboratory or after storage at 
(1) 4°C for a maximum of 16 h or (2) -80°C €or up 
to 3 days. Viral cultures were observed for cytopathic 
effect (CPE) three times per week for 3 weeks. Once 
enteroviral CPE had been observed, the culture was 
sent to the Virology Laboratory, Institute of Clinical 
Pathology and Medical Research (ICPMR), Westmead, 
Australia for typing by neutralization with pooled 
antisera. 
Polymerase chain reaction 
CSF specimens were stored at -80°C from 1 week to 
10 months before being tested in batches by PCR. The 
Amplicor PCR (APCR) assay detects coxsackievirus 
types A3, AS, A6, A7, A9-22, A24 and Bl-B6, 
echovirus types 1-9, 11-21, 24-27, 29 and 30-33, 
enteroviruses 68-71 and poliovirus types 1-3. 
Coxsackievirus types Al ,  2, 4 and 8 have not been 
tested by Roche, and echovirus types 22 and 23 cannot 
be detected at any titer. This assay was performed 
according to the manufacturer's instructions. Each assay 
run included one positive and three negative controls. 
Specimens were considered positive if they had an 
optical density greater than or equal to 0.35 at 450 nm. 
Analysis of discrepant results 
The medical records of patients whose results for PCR 
and culture were different were reviewed in an attempt 
to resolve discrepancies. When there was sufficient CSF 
remaining, specimens which were positive by PCR and 
negative by culture were sent to the Virology Depart- 
ment, the Royal Children's Hospital, Parkville, Victoria, 
Australia where specimens were retested by an 'in- 
house' PCR assay. 
Specimens were extracted using RNazol B 
(Biotech, Houston, TX, USA) as recommended, with 
modification. Briefly, 0.25 mL of CSF was mixed with 
100 pL of RNazol B containing 20 pg of glycogen 
(Boehringer Mannheim, Germany). After addition of 
40 pL of chloroform, the mixture was vortexed and 
incubated on ice for 5 min. Following centrifugation 
for 5 min at 12 OOOg, the upper phase was removed to 
a fresh tube and 0.25 mL of isopropanol was added. 
Samples were then mixed thoroughly and stored at 
-20OC for 1 h or overnight. RNA was pelleted by 
centrifugation at 12 000g for 10 min and the pellet was 
washed once with 70% ethanol before resuspending in 
15 pL of dstdled water containing 200 U / n L  RNazol 
(Promega, Madison, WI). 
Three primers were used in a semi-nested PCR 
protocol to amplifjr enterovirus cDNA. Primers were 
selected from three highly conserved parts of the 5' 
non-coding region. The upstream outer primer El ,  5'- 
GGC CCC TGA ATG CGG CTA AT-3', and the 
downstream inner primer E2, 5'-ATT GTC ACC 
ATA AGC AGC CA-3', have been described 
previously [10,14,16]. The sequence of the down- 
stream outer primer E3 was 5'-ATT GTC ACT GGA 
TGG CCA AT-3'; this is a unique sequence designed 
from a conserved region described previously [3]. Due 
to incomplete homology of E3 with all enteroviruses at 
the 5' end of the primer, a consensus sequence was 
designed. Amplification with the outer primers E l  and 
E3 results in a fragment of 197 bp, while semi-nested 
amplification with El  and E2 yields a 149-bp product. 
Enteroviral RNA was reverse transcribed and 
amplified using rTth DNA polymerase with a method 
modified from the manufacturers recommendations 
(Perkin-Elmer). Reactions were performed in 20 pL 
containing 5 pL of RNA sample, 1 xEZ buffer 
(Perkin-Elmer), 2.5 mM manganese acetate, 200 pM 
dNTPs, 1 pM primers E1/E3 and rTth DNA poly- 
merase buffer (Perkin-Elmer). The reactions were 
incubated at 50"C, 55°C and 60OC for 15 min at each 
temperature before DNA amplification for 40 cycles 
of 92 "C for 40 s, 55 O C  for 40 s and 60 O C  for 40 s. A 
volume of 1 pL of the reaction mixture was then added 
to the semi-nested PCR reaction in a total volume of 
20 pL containing 1 x taq buffer (Promega), 1.5 mM 
MgC12, 200 pM dNTPs, 1 pM primers E1/E2 and 
1 U Taq polymerase (Promega). Conditions for ampli- 
fication consisted of an initial denaturation at 94 "C for 
1 min before 25 cycles of 92°C for 40 s, 55OC for 
40 s and 72OC for 40 s. After amplification, the PCR 
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Table 1 APCR and viral-culture results for CSF specimens 
with and without pleocytosis 
Table 2 Details of patients whose CSF specimen was 
Amplicor PCR positive and viral culture negative 
Number of Number of 
Number of specimens specimens 
specimens positive by positive by 
CeU count/mm3 tested APCR viral culture 
101 28 18 
62 2 0 
Total 163 30 18 
products were analyzed by electrophoresis through 
1% agarose (FMC Bioproducts, Rockland, ME) and 
stained with ethidium bromide. Samples containing a 
149-bp product were considered positive. 
PCR on cerebrospinal fluid 
Table 1 shows the number of CSF specimens with and 
without pleocytosis that were positive by APCR and 
viral culture. Compared to viral culture of CSF only, 
the sensitivity of APCR was 100% (18/18), the 
specificity 91.7% (133/145), the positive predictive 
value 60% (18/30) and the negative predictive value 
100% (133/133). 
Echovirus type 30 was isolated from 12 specimens. 
Echovirus types 4 and 14 and coxsackievirus types A9 
and B4 were each isolated from one specimen. Two 
isolates were untypeable. The appearance of enteroviral 
CPE in viral culture took an average of 5 days (range: 
2-13 days). However, viral cultures were only read 
three times per week. If cultures were read daily, 
average time to detection of CPE may have been 
slightly less. Enteroviral isolation for other laboratories 
has ranged from 3.7 to 8.2 days [1,8,10,17]. 
Analysis of discrepant results 
There were 12 CSF specimens which were positive by 
APCR and negative by culture (Table 2). Five CSF 
specimens were tested by a supplementary 'in-house' 
PCR assay at another laboratory. Four of the CSF 
specimens positive by APCR were also positive by the 
supplementary PCR. Two further APCR-positive CSF 
specimens were thought to be true positives because of 
enterovirus isolation from another site. Therefore, s i x  
of the 12 APCR-positive, culture-negative specimens 
were considered to be true positives. All CSF specimens 
positive by culture were positive by APCR. However, 
one patient with evidence of enteroviral disease (serum 
PCR positive, echovirus 30 isolated from throat and 
stool) had a false-negative CSF APCR. The corrected 
Patient Supplementary 
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N T  
N T  
NT 
Echovirus 30 from 
throat and stool 
Echovirus 3 from 
throat and stool 
N T  
'Mother had probable echovirus 30 meningitis. 
Patients 1-6 were considered true positive by APCR. 
N T  = not tested. 
sensitivity of the APCR compared to culture of CSF, 
throat swab and stool specimens was 96.1%, the cor- 
rected specificity was 96.4% and the corrected positive 
and negative predictive values were 83.3% and 99.2% 
respectively. High sensitivity and specificity for the 
Roche PCR assay was demonstrated by Yerly et al [18]. 
They also found few borderline PCR results, with 
optical density (OD) values at least twice that of the 
cut-off. Our positive OD values reflect these findings, 
with 25 of the 33 having an OD value greater than 2.0. 
The lowest value was 0.85. 
DISCUSSION 
The results of this evaluation demonstrate that the 
Roche Amplicor PCR assay is significantly more 
sensitive than viral culture. If all APCR-positive results 
were regarded as true positives, viral culture of CSF was 
60% sensitive in this evaluation. Similar sensitivities for 
viral culture of 56% [17] and 65-75% [19] have been 
published, compared to PCR. The lack of sensitivity of 
viral culture may be due to the inability of some entero- 
viruses to grow in culture [7,10,16] or coverage ofvirus 
by antibodies which renders them incapable of attach- 
ing to and penetrating cells [7,16]. 
The negative CSF APCR result of one patient was 
thought to be a false negative. This patient had echo- 
virus type 30 isolated from both throat swab and stool 
specimens. Her daughter had also been diagnosed with 
echovirus type 30 meningitis. The serum of this patient 
was positive when tested for enterovirus by the APCR 
assay. This supports other evidence which suggests that 
the sensitivity of detection of enteroviral meningitis 
may be improved by the testing of acute serum speci- 
mens in addition to CSF [13]. However, serum APCR- 
positive results from children who have recently been 
vaccinated for polio should be interpreted with caution. 
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Polio vaccination has been shown to cause serum 
positive results for ‘in-house’ PCR assays [l]. 
Specificity of the APCR may well be better than 
it appears in this evaluation. Six of the 12 APCR- 
positive, culture-negative CSF specimens were regarded 
as true positives. The remaining six discrepant specimens 
could not be confirmed as true positives due to the lack 
of remaining CSF available for supplementary P C R  
testing. Stool and throat swab specimens from these six 
patients were not submitted for viral culture. However, 
no other pathogens were detected from these patients 
and all patients had symptoms w l c h  were consistent 
with viral meningitis. 
We decided to investigate what effect there would 
be on patient management if the APCR assay was 
routinely performed on CSF specimens with a raised 
W C C  and no evidence of bacteria. 
The medical records of the 28 CSF PCR-positive 
patients among the 101 patients with a raised CSF 
W C C  were reviewed. There were 12 patients who 
were not treated with antibiotics. Their length of stay 
in hospital varied from 4 h to 4 days. All of these 
patients had a differential CSF W C C  of less than 50% 
polymorphonuclear leukocytes (PMLs). If these 12 
patients had been discharged earlier, at the time we 
issued a positive APCR result, the total hospital stay 
would have been reduced by 11 patient days. The other 
16 patients were all treated with antibiotics. The CSF 
differential cell count showed greater than 50% PMLs 
in 13 of these patients. In this group of patients the 
duration of admission ranged from 2 to 10 days. Forty- 
three days of hospitalization would have been prevented 
and $AU1134 (all amounts expressed in Australian 
dollars) saved in antibiotic costs if these patients had 
been discharged on receipt of a positive enteroviral CSF 
P C R  result. This total of 54 days potentially saved is 
based on the assumption that the P C R  assay will be 
available 9 AM to 5 PM, Monday to Friday. The overall 
saving representing hospital accommodation and anti- 
biotic use is $AU27 324. 
If the test were to be performed daily, it would 
often be necessary to test one specimen per assay plus 
a positive and negative control, which would triple the 
cost of reagents and consumables per patient. The total 
maximum cost per patient, including materials and 
labor, was estimated to be $AU113. 
The maximum cost of 101 tests (which represents 
the group of patients reviewed) is $AUll  413. Sub- 
tracting this amount from the overall estimated saving 
of $AU27 324 results in a net saving of $AU15 911. 
The estimated savings are hypothetical and assume 
that the patient will be discharged on the day that 
positive APCR results are received. There will, how- 
ever, be situations where the patient will be kept in 
hospital if the clinician decides that further observation 
or supportive care is required. The cost of the assay per 
patient will also be significantly reduced as the number 
of patients tested per assay run increases. 
Despite the cost of this assay, the potential saving 
due to decreased duration of hospital accommodation 
and decreased use of antibiotics may well justifi. the 
routine use of APCR. We suggest only screening CSFs 
with a raised W C C  ( 2 5  /mm3) because of the higher 
prevalence of positives in this group (26% for high 
W C C  versus 3.3% for normal WCC in this study). In 
a study by Schlesinger et al [17] it was estimated that 
for a group of 27 infants with pleocytosis, an average 
of 1.2 days per patient may have been saved by early 
reporting of their ‘in-house’ P C R  result. However, the 
study included 12 patients whose P C R  result was 
negative. For the 15 PCR-positive patients, an average 
of 2.2 days per patient could have been saved. Overall, 
1.9 days per patient may have been saved for the 28 
patients reviewed in our study. 
The Amplicor P C R  assay can be performed in 
5 h. Herein lies one of the major benefits of using 
the APCR assay routinely for diagnosis of entero- 
viral meningitis. Whereas viral culture rarely impacts 
on patient management, due to the time taken for 
an enterovirus to grow [17], P C R  has the potential to 
directly affect patient management if performed on a 
daily basis by reducing hospital stay and the use of 
antibiotics [8,17]. Early diagnosis of enterovirus 
meningitis resulting in the possible reduction of 
hospitahzation has other benefits, such as reduction of 
intravascular device complications and reduced ex- 
posure to nosocomial infections [20]. 
This evaluation has demonstrated that the Roche 
Amplicor P C R  assay for the detection of enteroviruses 
from CSF is both sensitive and specific. The use of this 
assay in a routine diagnostic laboratory can be justified 
in two ways: 
1. greater sensitivity of detection of viral meningitis; 
2. the savings which result from reduction of hospital 
accommodation and antibiotic use due to early 
reporting of a positive P C R  result, which offset 
the cost of the assay. 
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